Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Arterial Vascular Engineering AVEI -- Ignore unavailable to you. Want to Upgrade?

To: Walk Softly who wrote (184)	4/27/1998 11:38:00 AM
From: LAWREAL	Read Replies (2) \| Respond to of 410

FRom Briefing.com Arterial Vascular Engineering Inc. (AVEI) 32 3/8 -5/8: Adams Harkness initiates coverage of coronary stent company with "market perform" as sales of fast growing stent market are flattening in Europe, which does not bode well for the US market; expects AVEI to have three sequential flat quarters in revenues next year and for earnings comparisons to be down in the second half of FY99; expects company to earn $1.60 in FY98 and $2.13 in FY99.....